Figure 5.
Cutellarin reduced Aβ burden in the scutellarin treated APP/PS1 mice. (A–D) Aβ plaques in cortex and hippocampus of control transgenic mice; (B–E) APP/PS1 transgenic mice treated with scutellarin diet; (C) Comparison of Aβ plaque area fraction in neocortex and hippocampus between groups. * p < 0.05 versus APP/PS1 control mice. Scale bar = 0.5 mm. Original magnification, 4×.